Treatment as Prevention¨

It’s time for Toronto to step up: Let’s become a UNAIDS Fast-Track City

The past few years have been a rollercoaster for those of us most impacted by HIV. The use of pre-exposure prophylaxis (PrEP) by people who are HIV-negative has gone from being discredited and shamed to become one of the keystones of a renewed and revitalized push to “end the HIV epidemic”. The other life-changing piece

It’s time for Toronto to step up: Let’s become a UNAIDS Fast-Track City Read More »

PrEP can ‘significantly’ reduce HIV rates across populations, study says

(CNN) – HIV pre-exposure prophylaxis or PrEP, the use of drugs to prevent HIV infection, among men who have sex with men can significantly reduce new infections across an entire population of men, a new study finds. Based on introduction of the intervention, HIV infections diagnosed in men who have sex with men in the

PrEP can ‘significantly’ reduce HIV rates across populations, study says Read More »

AIDS Drug Assistance Programs Must Navigate Costs and Needs of People With HIV

The ADAP Advocacy Association hosted its annual conference in late September, and it covered many subject areas along this year’s official theme, “Mapping a New Course to Protect the Public Health Safety Net.” The AIDS Drug Assistance Program, which was first established by Congress to pay for Retrovir (zidovudine, AZT) in 1987, was then incorporated

AIDS Drug Assistance Programs Must Navigate Costs and Needs of People With HIV Read More »

A Global Health Evangelist Is Shocked To Hear He’s A ‘Genius’

Gregg Gonsalves took a wild, meandering path to the Ivory Tower. His route to becoming a professor at Yale started in street protests and spanned the globe. On Thursday he was honored with a prestigious MacArthur Fellowship. Gonsalves is one of this year’s MacArthur “geniuses.” The award from the John D. and Catherine T. MacArthur

A Global Health Evangelist Is Shocked To Hear He’s A ‘Genius’ Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below